CA9 and nonpapillary renal cell carcinoma: Approximately80–90% of patients with ccRCC carry mutations in the von Hippel–Lindau(VHL) tumor suppressor gene, leading to stabilization of hypoxia-inducibletranscription factors (HIF-1α, HIF-2α) and subsequentoverexpression of target genes, including CAIX.